Form D · Other

RxE2 Inc.

Fargo, ND · CIK 0001855833

Offering snapshot reported Apr 19, 2021 · SEC filing

Reported sold
$2M
Offering amount: $2M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 31, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1M$2MApr 19, 2021: $1.00Apr 19, 2021Apr 19, 2021: $2,000,000.00Apr 19, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1 → $2,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 19, 2021Initial$1No comparison0SEC filing
Apr 19, 2021Initial$0No comparisonNot reportedSEC filing
Apr 19, 2021Amendment$2,000,000$1,999,999vs Apr 19, 20210SEC filing
Apr 8, 2021Initial$1No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-396320
Series Seed Preferred

Source: Form D, filed Apr 19, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gerald E. Finken Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
4302 13 Th Ave S, Ste. 4326
Fargo, ND, 58103